Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Belimumab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02270970
What this trial is testing

Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy

Who this might be right for
Systemic Lupus Erythematosus
Oklahoma Medical Research Foundation 20
Early research (Phase 1)Study completedNCT04136145
What this trial is testing

Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 36
Not applicableStudy completedNCT01914770
What this trial is testing

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 1,016
Early research (Phase 1)Study completedNCT03207958
What this trial is testing

Belimumab for Prevention of Chronic Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Vs Host DiseaseGraft-versus-host-disease
Washington University School of Medicine 10
Testing effectiveness (Phase 2)Looking for participantsNCT03844061
What this trial is testing

Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Hospital for Special Surgery, New York 30
Not applicableStudy completedNCT04570306
What this trial is testing

Transcriptional and Immune Parameters of Response to Belimumab

Who this might be right for
Systemic Lupus Erythematosus
Biomedical Research Foundation, Academy of Athens 85
Post-approval studies (Phase 4)Looking for participantsNCT07225387
What this trial is testing

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

Who this might be right for
Lupus Nephritis
NephroNet, Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT01440361
What this trial is testing

Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline
Early research (Phase 1)Study completedNCT02880852
What this trial is testing

Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 20
Post-approval studies (Phase 4)Study completedNCT04908865
What this trial is testing

Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 67
Large-scale testing (Phase 3)Study completedNCT02119156
What this trial is testing

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 80
Large-scale testing (Phase 3)UnknownNCT05863936
What this trial is testing

Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

Who this might be right for
Lupus NephritisRemissionSafety Issues
Nanjing University School of Medicine 15
Large-scale testing (Phase 3)Study completedNCT00724867
What this trial is testing

A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc., a GSK Company 268
Early research (Phase 1)Study completedNCT00657007
What this trial is testing

Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 70
Large-scale testing (Phase 3)Looking for participantsNCT06716606
What this trial is testing

Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

Who this might be right for
Connective Tissue Diseases
GlaxoSmithKline 514
Large-scale testing (Phase 3)Study completedNCT01639339
What this trial is testing

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Human Genome Sciences Inc., a GSK Company 448
Testing effectiveness (Phase 2)Looking for participantsNCT07340463
What this trial is testing

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Nanjing University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT05154734
What this trial is testing

Efficacy and Safety of Belimumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
NMO Spectrum Disorder
Tianjin Medical University General Hospital 14
Testing effectiveness (Phase 2)WithdrawnNCT01762852
What this trial is testing

Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy

Who this might be right for
Glomerulonephritis, Membranous
GlaxoSmithKline
Testing effectiveness (Phase 2)Looking for participantsNCT03949855
What this trial is testing

Belimumab With Rituximab for Primary Membranous Nephropathy

Who this might be right for
Membranous NephropathyNephrotic Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 58
Next Page